Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2016-001611-20-DE
EUCTR2016-001611-20-DE
Active, not recruiting
Phase 1

Pathophysiology-based therapy of epileptic encephalopathies

niversity of Tübingen0 sites25 target enrollmentSeptember 26, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsVimpat Syrup

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Tübingen
Enrollment
25
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2016
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity of Tübingen

Eligibility Criteria

Inclusion Criteria

  • •\- highly active epilepsy (one or more seizures per day) with onset at 3 months of age or before \- pharmo\-resistance (2 or more anticonvulsive medications tried before with no effect) \- max. 2 stable anticonvulsive drugs at study start
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 25
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range 0
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • •\- high\-grade cardial rhythm disease \- severe pathology of liver or renal function \- severe change in blood counts or electrolytes \- metabolic or lesional epilepsy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Study on the pathophysiology of epilepsy using a [18F]BCPP-EF PET tracer
JPRN-UMIN000044752Department of Biofunctional Imaging, Hamamatsu University School of Medicine60
Recruiting
Phase 4
Treatment of Established Status Epilepticus in the Elderly - a prospective, randomized, double-blind comparative effectiveness trialG41.9Status epilepticus, unspecified
DRKS00022308niversität Leipzig132
Completed
Not Applicable
Epileptology and NeuroPalliativeCare: Seizures in End of LifePatients with incurable, advanced diseases with epileptic seizures and palliative care needs.
DRKS00031864Charité - Universitätsmedizin Berlin110
Withdrawn
Phase 2
Pathophysiology Based Therapy of Early Onset Epileptic EncephalopathiesSeizure, Epileptic
NCT02968966University Hospital Tuebingen
Recruiting
Phase 2
Cerebellar stimulation to treat refractory epilepsy in childrerefractory epilepsy10039911
NL-OMON55396Erasmus MC, Universitair Medisch Centrum Rotterdam9